Jan Mous

Dr Mous recently joined Integragen as President and Chief Executive Officer in July 2003.
Dr Mous is also a Member of the Scientific Advisory Board of Proteosys, a biotechnology company; and the Scientific Expert Committee of "First Ventury", a venture capital firm.
Dr Mous has nearly twenty (20) years working in the bio-pharmaceuticals industry primarily at F.
Hoffman-La Roche and most recently LION Bioscience.
Dr. Mous was Global Head of Genomics Technologies (1998-2000), deputy Head CNS research (1997-1998), Head Gene Technology/Genomics (1994-1997), Head Molecular Biology (1991-1994) and Head AIDS research and Molecular Virology (1985-1994) at F.Hoffmann-La Roche Ltd, Basel, Switzerland.
Also at Roche, Dr Mous initiated and managed alliances with Incyte and Affymetrix, initiated the first pharmaco- and toxico-genomics programs, and led the creation of the proteomics project.
Dr Mous then served as Chief Scientific Officer at LION Biosciences, enjoying the firm winning the Most Successful IPO of the Year award in 2000.
Dr Mous is author of over 80 publications in international journals.
He served as a lecturer, tutor and supervisor to various universities including those of Basel, Bern, Brussels, Leuven, and Zurich.
He is also a "Privatdozent" at the University of Basel.